Serious Skin Reaction Associated with Imatinib in a Patient with Chronic Myeloid Leukemia

Serious Skin Reaction Associated with Imatinib in a Patient with Chronic Myeloid Leukemia

Imatinib mesylate (STI 571) is one of the fundamental chemotherapeutic agents used in the treatment of the chronic, accelerated and blastic phases of chronic myelocytic leukemia (CML), gastrointestinal stromal tumors and Philadelphia chromosome–positive acute lymphoblastic leukemia. It selectively i...

Full description

Bibliographic Details
Main Authors: Murat Albayrak, Harika Celebi, Aynur Albayrak, Esra Saribacak Can, Vedat Aslan, Birgul Onec, Ipek Coban
Format: Article
Language:English
Published: AVES 2011-12-01
Series:Eurasian Journal of Medicine
Subjects:
Chronic myelocytic leukemia (CML)
Imatinib
Skin lesions
Online Access:http://www.eajm.org/text.php3?id=416

Internet

http://www.eajm.org/text.php3?id=416

Similar Items